Early DMARD Initiation Improves Disease Control in Psoriatic Arthritis, Suggests Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Treatment of psoriatic arthritis focuses on: Β Stopping progression of the disease.Β Reducing inflammation. Β Treating skin symptoms.Β Relieving pain. Β Keeping joints as mobile as possible.Β Early, aggressive treatment of PsA helps to minimize the effect of the disease on your quality of life. Managing psoriatic arthritis can seem like treating two diseases. Β Since…
Active Psoriatic Arthritis during pregnancy may Increase Risk of Hypertensive Pregnancy Disorders: BMJ We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Biocon Biologics Gets Health Canada Nod for Yesintek, a Biosimilar to Stelara We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Central Obesity Linked to Higher Disease Severity in Psoriatic Arthritis: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
JnJ Tremfya gets USFDA nod for pediatric plaque psoriasis, active psoriatic arthritis We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Psoriatic Arthritis Patients Face Higher Burden of Metabolic Syndrome, Meta-Analysis Shows We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Tildrakizumab Shows Significant Efficacy in Psoriatic Arthritis Phase 3 Trials We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
CDSCO Panel Accepts Glenmark’s Apremilast Trial Report, Seeks 2-Year PSUR Data We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Eli Lilly Gets CDSCO Panel Nod for Ixekizumab Safety Label Update We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link